Furthermore, MA-35 might affect the recovery of epigenetic modifications and inhibit TNF-α/IKK and TGF-β1/Smad3 signaling to attenuate renal fibrosis (Figure 5, Shima et al., 2017). The gene discussed is SMAD3; the disease is renal fibrosis.